Wenge Wang - Search Results

Year	Number of Results
1992	1
1995	1
2002	7
2003	3
2004	5
2005	6
2006	4
2007	3
2008	7
2009	4
2010	3
2011	4
2012	5
2013	1
2014	2
2015	5
2016	3
2017	6
2018	7
2019	5
2020	8
2021	4
2022	3
2023	5
2024	3

1

Malignant melanoma-The cradle of anti-neoplastic immunotherapy.

Koller KM, Wang W, Schell TD, Cozza EM, Kokolus KM, Neves RI, Mackley HB, Pameijer C, Leung A, Anderson B, Mallon CA, Robertson G, Drabick JJ. Koller KM, et al. Among authors: wang w. Crit Rev Oncol Hematol. 2016 Oct;106:25-54. doi: 10.1016/j.critrevonc.2016.04.010. Epub 2016 May 7. Crit Rev Oncol Hematol. 2016. PMID: 27637351 Review.

2

Evolution of a comprehensive, orthogonal approach to sequence variant analysis for biotherapeutics.

Lin TJ, Beal KM, Brown PW, DeGruttola HS, Ly M, Wang W, Chu CH, Dufield RL, Casperson GF, Carroll JA, Friese OV, Figueroa B Jr, Marzilli LA, Anderson K, Rouse JC. Lin TJ, et al. Among authors: wang w. MAbs. 2019 Jan;11(1):1-12. doi: 10.1080/19420862.2018.1531965. Epub 2018 Oct 25. MAbs. 2019. PMID: 30303443 Free PMC article. Review.

3

Current strategies to target p53 in cancer.

Chen F, Wang W, El-Deiry WS. Chen F, et al. Among authors: wang w. Biochem Pharmacol. 2010 Sep 1;80(5):724-30. doi: 10.1016/j.bcp.2010.04.031. Epub 2010 May 5. Biochem Pharmacol. 2010. PMID: 20450892 Review.

4

Restoration of p53 to limit tumor growth.

Wang W, El-Deiry WS. Wang W, et al. Curr Opin Oncol. 2008 Jan;20(1):90-6. doi: 10.1097/CCO.0b013e3282f31d6f. Curr Opin Oncol. 2008. PMID: 18043262 Review.

5

Quantum chaos and the correspondence principle.

Wang J, Benenti G, Casati G, Wang WG. Wang J, et al. Phys Rev E. 2021 Mar;103(3):L030201. doi: 10.1103/PhysRevE.103.L030201. Phys Rev E. 2021. PMID: 33862813

6

Rating the quality of evidence: the GRADE system in systematic reviews/meta-analyses of AKI.

Kong Y, Wei X, Duan L, Wang W, Zhong Z, Ming Z, Zeng R. Kong Y, et al. Among authors: wang w. Ren Fail. 2015 Aug;37(7):1089-93. doi: 10.3109/0886022X.2015.1056065. Epub 2015 Sep 2. Ren Fail. 2015. PMID: 26329506 Review.

7

Structural and functional basis for therapeutic modulation of p53 signaling.

Bassett EA, Wang W, Rastinejad F, El-Deiry WS. Bassett EA, et al. Among authors: wang w. Clin Cancer Res. 2008 Oct 15;14(20):6376-86. doi: 10.1158/1078-0432.CCR-08-1526. Clin Cancer Res. 2008. PMID: 18927276 Review.

8

Henoch-schonlein Purpura Nephritis with Renal Interstitial Lesions.

Liu F, Wang C, Wang R, Wang W, Li M. Liu F, et al. Among authors: wang w. Open Med (Wars). 2018 Nov 27;13:597-604. doi: 10.1515/med-2018-0088. eCollection 2018. Open Med (Wars). 2018. PMID: 30519637 Free PMC article.

9

Cysteine metabolic engineering and selective disulfide reduction produce superior antibody-drug-conjugates.

Procopio-Melino R, Kotch FW, Prashad AS, Gomes JM, Wang W, Arve B, Dawdy A, Chen L, Sperry J, Hosselet C, He T, Kriz R, Lin L, Marquette K, Tchistiakova L, Somers W, Rouse JC, Zhong X. Procopio-Melino R, et al. Among authors: wang w. Sci Rep. 2022 May 4;12(1):7262. doi: 10.1038/s41598-022-11344-z. Sci Rep. 2022. PMID: 35508689 Free PMC article.

10

Restoring p53-dependent tumor suppression.

Wang W, Rastinejad F, El-Deiry WS. Wang W, et al. Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S55-63. Cancer Biol Ther. 2003. PMID: 14508081 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

98 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year